Compugroup Medical SE (ETR:COP) has been given a €60.00 ($70.59) price target by analysts at Deutsche Bank AG in a research note issued on Monday. The brokerage currently has a “buy” rating on the stock.

Several other equities analysts have also recently commented on the stock. HSBC Holdings plc set a €60.00 ($70.59) target price on shares of Compugroup Medical SE and gave the company a “buy” rating in a research note on Wednesday, July 5th. Baader Bank set a €52.00 ($61.18) target price on shares of Compugroup Medical SE and gave the company a “buy” rating in a research note on Friday, July 14th. Warburg Research set a €52.00 ($61.18) target price on shares of Compugroup Medical SE and gave the company a “neutral” rating in a research note on Tuesday, June 20th. Finally, Berenberg Bank set a €53.00 ($62.35) target price on shares of Compugroup Medical SE and gave the company a “neutral” rating in a research note on Friday, August 4th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Compugroup Medical SE currently has an average rating of “Hold” and an average target price of €55.40 ($65.18).

Shares of Compugroup Medical SE (ETR COP) opened at 49.875 on Monday. Compugroup Medical SE has a 52-week low of €36.21 and a 52-week high of €52.80. The stock has a 50 day moving average of €48.60 and a 200 day moving average of €48.13. The company has a market cap of €2.48 billion and a P/E ratio of 54.508.

WARNING: This piece was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international trademark and copyright law. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/10/18/compugroup-medical-se-cop-given-a-60-00-price-target-by-deutsche-bank-ag-analysts.html.

About Compugroup Medical SE

CompuGroup Medical Societas Europaea develops and sells software, as well as information technology services for healthcare sector worldwide. It operates through three segments: Health Provider Services I, Health Provider Services II, and Health Connectivity Services. The company is involved in the development and sale of practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physicianÂ’s networks; and integral clinical, administrative, and financial software applications for pharmacies and mail order pharmacies.

Analyst Recommendations for Compugroup Medical SE (ETR:COP)

Receive News & Stock Ratings for Compugroup Medical SE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical SE and related stocks with our FREE daily email newsletter.